This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Timothy Ring Biography and Net Worth

Director of Quest Diagnostics

Timothy M. Ring serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Ring has been a member of the board since 2017, previously serving as chairman and chief executive officer of C. R. Bard, Inc. from 2003 to 2017.

Ring also is lead director of Quest Diagnostics Incorporated, and a co-founder of TEAMFund, Inc., an impact fund focused on delivering medical technology to sub-Saharan Africa and India.

With over 20 years of experience in various leadership positions at Bard, Ring offers a unique perspective on the Bard business. As an experienced chief executive officer of a public company, Ring also contributes expertise in many facets of business, including strategy, product development and international operations, and has extensive experience in the healthcare industry.

What is Timothy M. Ring's net worth?: The estimated net worth of Timothy M. Ring is at least $3.32 million as of December 1st, 2022. Mr. Ring owns 24,149 shares of Quest Diagnostics stock worth more than $3,321,695 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Ring may own. Learn More about Timothy M. Ring's net worth.
How do I contact Timothy M. Ring?: The corporate mailing address for Mr. Ring and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Timothy M. Ring's contact information.
Has Timothy M. Ring been buying or selling shares of Quest Diagnostics?: Timothy M. Ring has not been actively trading shares of Quest Diagnostics during the last quarter. Most recently, Timothy M. Ring sold 2,025 shares of the business's stock in a transaction on Thursday, December 1st. The shares were sold at an average price of $152.50, for a transaction totalling $308,812.50. Following the completion of the sale, the director now directly owns 24,149 shares of the company's stock, valued at $3,682,722.50. Learn More on Timothy M. Ring's trading history.
Who are Quest Diagnostics' active insiders?: Quest Diagnostics' insider roster includes Michael Deppe (CAO), Catherine Doherty (SVP), Mark Guinan (CFO), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.
Are insiders buying or selling shares of Quest Diagnostics?: In the last twelve months, insiders at the medical research company sold shares 5 times. They sold a total of 15,150 shares worth more than $1,913,201.65. The most recent insider tranaction occured on February, 29th when SVP Michael E Prevoznik sold 5,611 shares worth more than $706,312.68. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.
Information on this page was last updated on 2/29/2024.

Timothy M. Ring Insider Trading History at Quest Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2022	Sell	2,025	$152.50	$308,812.50	24,149
11/1/2022	Sell	2,000	$144.06	$288,120.00	24,149
10/3/2022	Sell	2,000	$123.39	$246,780.00	23,933
8/1/2022	Sell	2,000	$136.04	$272,080.00	23,933
7/1/2022	Sell	2,000	$133.47	$266,940.00	23,933

Timothy M. Ring Buying and Selling Activity at Quest Diagnostics

Quest Diagnostics Company Overview

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Today's Range

Now: $137.55

$134.95

$138.32

50 Day Range

MA: $128.69

$123.80

$137.55

2 Week Range

Now: $137.55

$119.59

$148.62

Volume

1,566,421 shs

Average Volume

995,468 shs

Market Capitalization

$15.28 billion

P/E Ratio

18.51

Dividend Yield

2.21%

Beta

0.91